Abstract
NK cells are critical innate effector cells that serve as first responders to many viral diseases and in surveillance of early malignant transformation. Improved understanding of their biology, recognition of their importance in cancer treatment (particularly in the setting of bone marrow transplantation), and development of approaches for augmenting function and generating cells for adoptive immunotherapy have enabled a new era of clinical trials aimed at improving number and function of these cells for clinical benefit.
| Original language | English (US) |
|---|---|
| Title of host publication | Immunotherapy in Translational Cancer Research |
| Publisher | Wiley-Blackwell |
| Pages | 215-227 |
| Number of pages | 13 |
| ISBN (Electronic) | 9781118684535 |
| ISBN (Print) | 9781118123225 |
| DOIs | |
| State | Published - Apr 13 2018 |
Bibliographical note
Publisher Copyright:© 2018 John Wiley & Sons, Inc. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adoptive immunotherapy
- Antibody-dependent cellular cytotoxicity
- Hematopoietic stem cell transplantation
- IL-15
- IL-2
- KIR-mismatch
- Natural killer cells
Fingerprint
Dive into the research topics of 'Natural Killer Cell-Based Immunotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS